Sangamo Therapeutics Inc. buy Barclays PLC
Start price
14.11.24
/
50%
€2.12
Target price
14.11.25
€8.52
Performance (%)
-81.54%
End price
15.11.25
€0.39
Summary
This prediction ended on 15.11.25 with a price of €0.39. Massive losses of -81.54% were the result for the BUY prediction by Barclays_PLC. Barclays_PLC has a follow-up prediction for Sangamo Therapeutics Inc. where he still thinks Sangamo Therapeutics Inc. is a Buy. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Sangamo Therapeutics Inc. | 2.133% | 2.133% | -65.899% |
| iShares Core DAX® | 2.331% | 5.140% | 25.000% |
| iShares Nasdaq 100 | 2.077% | 2.956% | 8.935% |
| iShares Nikkei 225® | 2.759% | 7.214% | 22.171% |
| iShares S&P 500 | 1.613% | 2.893% | 6.249% |
Comments by Barclays_PLC for this prediction
In the thread Sangamo Bioscienes diskutieren
Sangamo Therapeutics, Inc. (NASDAQ: SGMO) had its price target raised by analysts at Barclays PLC from $3.00 to $9.00. They now have an "overweight" rating on the stock.
Ratings data for SGMO provided by MarketBeat
In the thread Trading Sangamo Bioscienes
Die von Barclays_PLC gewählte maximale Laufzeit wurde überschritten
Current prediction by Barclays_PLC for Sangamo Therapeutics Inc.
Sangamo Therapeutics Inc.
Start price
Target price
Perf. (%)
€0.41
14.05.25
14.05.25
€4.47
14.05.26
14.05.26
-5.73%
13:32
13:32
